BioQ Devices is a pre-clinical stage medical device company developing patented extra aortic balloon counterpulsation technology that targets drug resistance hypertension and moderate heart failure suffers.
Over 5 million patients suffer heart failure in the USA alone and at least 1 million of this group are suitable for treatment using the BioQ Cardiac Assist system. The minimum global market opportunity for the BioQ CAS has been valued at over USD$1 Billion/year and is estimated to grow in excess of the CRT/D market of $3B pa. The device can be used to treat hypertension and targets the additional market opportunity of 24% of the 73 million people in the United States with inadequate control of their hypertension.
The self-powered extra aortic counterpulsation system being developed by BioQ, treat’s heart failure by reducing afterload and increasing coronary artery blood flow, using the proven principles of aortic counterpulsation delivered in a new revolutionary approach that is aimed at reducing treatment risks and enhancing treatment outcomes in a cost effective and preventative manner.
For more information on BioQ Devices, email info@bioqdevices.com
Company Details
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.bioqdevices.com
Bioq Devices Pty Ltd Questions
Bioq Devices Pty Ltd's website is http://www.bioqdevices.com
Bioq Devices Pty Ltd's LinkedIn profile is https://www.linkedin.com/company/bioq-devices-pty-ltd
Bioq Devices Pty Ltd's industry is
Medical Equipment Manufacturing
Bioq Devices Pty Ltd's top competitors are
Aortyx,
Kitea Health,
Prytime Medical Devices, Inc.,
Gebs Med (Pvt) Ltd,
Petrofac,
Upstream Medical Technologies Ltd,
Dewpoint Innovations,
Mcm Medsys,
Qheart Medical.
Bioq Devices Pty Ltd's categories are Medical Equipment Manufacturing
